Rationale: Disruption of endothelial barrier function and neutrophil-mediated injury are two major mechanisms underlying the pathophysiology of sepsis-induced acute lung injury (ALI). Recently we reported that endotoxin induced activation of RhoA in mice lungs that led to the disruption of endothelial barrier and lung edema formation; however, the molecular mechanism of this phenomenon remained unknown. Objective: We reasoned that LIMK1, which participates in the regulation of endothelial cell contractility and is activated by RhoA/Rho kinase pathway, could mediate RhoA-dependent disruption of endothelial barrier function in mouse lungs during ALI. And if that is the case, then attenuation of endothelial cell contractility by downregulating LIMK1 may lead to the enhancement of endothelial barrier function, which could protect mice from endotoxin-induced ALI. Methods and Results: Here we report that LIMK1 deficiency in mice significantly reduced mortality induced by endotoxin. Data showed that lung edema formation, lung microvascular permeability, and neutrophil infiltration into the lungs were suppressed in limk1 ؊/؊ mice. Conclusions: We identified that improvement of endothelial barrier function along with impaired neutrophil chemotaxis were the underlying mechanisms that reduced severity of ALI in limk1 ؊/؊ mice, pointing to a new therapeutic target for diseases associated with acute inflammation of the lungs. (Circ Res. 2009;105:549-556.) Key Words: LIMK1 Ⅲ
S epsis is the most common cause of acute lung injury (ALI), a syndrome that results from acute pulmonary edema and inflammation. 1 The pathogenesis of ALI includes disruption of endothelial barrier that leads to lung edema, 2 and activation of neutrophils by cytokines, which results in neutrophil infiltration and tissue damage. 3, 4 RhoA regulates both endothelial barrier function and neutrophil function. In endothelial cells, RhoA promotes actin polymerization and actomyosin-based cell contractility, which leads to the disruption of endothelial barrier function. 5 In neutrophils, RhoA regulates cell migration through signaling that leads to myosin light chain phosphorylation and actin polymerization. 6 We reported recently that endotoxin (LPS) induced activation of RhoA in mouse lungs in vivo, which resulted in the disruption of the endothelial barrier and lung edema formation. 7 RhoA/Rho kinase (ROCK) signaling cascade was involved in the disruption of the endothelial barrier function in mouse lungs because LPS- 8 and peptide agonist corre-sponding to the tethered ligand sequence of human PAR-1 (SFLLRN) (PAR-1)-induced 7 increases in vascular permeability were reversible by pharmacological inhibition of ROCK.
We hypothesized that LIMK1, which downstream of ROCK 9 mediates endothelial cells contractility, 10 regulates RhoA-dependent disruption of endothelial barrier function in mouse lungs during ALI. We also hypothesized that attenuation of endothelial cell contractility by downregulation of LIMK1 may lead to the enhancement of endothelial barrier function, which ultimately could protect mice during endotoxin-induced acute lung injury. In addition, as actin polymerization is required for the efficient neutrophils chemotaxis, we reasoned that lack of LIMK1 would impair neutrophil migration, leading to decreased diapedesis.
Here we demonstrated that LPS induced activation of RhoA and LIMK1 in the mouse lungs in vivo. To study the role of LIMK1 in ALI, we used limk1 Ϫ/Ϫ mice. Importantly, the severity of ALI was decreased in limk1 Ϫ/Ϫ mice, as was observed by increased survival rate, decreased edema formation, and polymorphonuclear leukocytes (PMN) infiltration in the lungs. We found that LIMK1 regulated RhoA-mediated LPS-induced increase in microvascular permeability. Our data showed that downregulation of LIMK1 resulted in the improvement of the endothelial barrier function both in vivo and in cell culture models. We demonstrated that, mechanistically, LIMK1 mediated endothelial barrier disruption through phosphorylation of its downstream target, cofilin. Finally, we determined that limk1 Ϫ/Ϫ PMN exhibited decreased chemotactic ability attributable to reduced actin polymerization.
Taking into account that genetic deletion of LIMK1 in mice resulted only in minor systemic effects, 11 we propose that organ-specific (targeted) downregulation or inhibition of kinase activity of LIMK1 could be an effective strategy to (1) improve endothelial barrier function, leading to less permeable blood vessels, and to (2) decrease neutrophil infiltration in lungs that might be beneficial during acute lung injury.
Methods
Detailed description of materials, animal procedures, lung preparation and Kfc measurements, tissue collection and preparation for biochemical assays, electron microscopy studies, immunohistochemistry, ECIS studies, PMN isolation and superoxide production, degranulation, and chemotaxis assays are provided in the Data Supplement (available online at http://circres.ahajournals.org).
Animals
All animal procedures were carried out following the Public Health Service Policy on Humane Care of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of University of Illinois at Chicago.
Statistical Analysis
For statistical analysis, paired 2-tailed Student t test was used to compare data between 2 groups. ANOVA test was used to compare several groups. Log-rank test was used to assess differences in mortalities. Values are expressed as meanϮSEM. PϽ0.05 was considered statistically significant.
Results

Genetic Deletion of LIMK1 Decreases Severity of ALI in Mice
LIMK1 and LIMK2 proteins are expressed in lungs and in neutrophils both in mice and humans 12, 13 (Figure 1A through 1C). Genetic deletion of LIMK1 did not result in the upregulation of LIMK2 expression ( Figure 1B and 1C ).
As a model of ALI, where lung is injured indirectly, and which targets primarily the capillary endothelium, 14 we chose intraperitoneal administration of LPS. Initially we determined whether LIMK1 was activated in this model of ALI. LPS, at 23 mg/kg (LD 50 for limk1 Ϫ/Ϫ mice; data not shown), induced activation and phosphorylation of LIMK1 in limk1 ϩ/ϩ mice ( Figure 1D ). To address the question whether genetic deletion of LIMK1 may attenuate the severity of ALI, LPS was given to the limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice, and the survival rate was assessed over period of 7 days. limk1 Ϫ/Ϫ mice displayed an increased survival rate as compared to limk1 ϩ/ϩ littermates (from 23.8% limk1 ϩ/ϩ to 52.38% limk1 Ϫ/Ϫ ; Pϭ0.0468; Figure 1E ). Pulmonary edema, which serves as a hallmark of this disease, 15 is one of the factors contributing to the mortality of patients with ALI. 1 LPS challenge resulted in the formation of pulmonary edema 16 that was significantly re- Figure 1F ).
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Downregulation of LIMK1 Enhances Endothelial Barrier Function In Vivo and in Cell Culture Models
Disruption of the endothelial barrier function is a major contributor to the lung edema development. 2 To compare the endothelial barrier function in limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice, we determined the pulmonary microvessel filtration coefficient (Kfc), a quantitative measure of vascular permeability, using isolated-perfused lung model. 17 Genetic deletion of LIMK1 resulted in a significant decrease of Kfc in a basal state ( Figure 2A ). LPS-induced Kfc was also significantly smaller in limk1 Ϫ/Ϫ mice ( Figure 2A ). Observed decrease in vascular permeability may serve as an explanation for the decreased lung edema formation in limk1 Ϫ/Ϫ mice. RhoA family GTPases regulate endothelial barrier function via modulation of the actin cytoskeleton dynamics. 5 Activation of RhoA destabilizes, whereas activation of Rac1 and Cdc42 signaling pathways enhance the barrier function. 5 We addressed the possibility of compensatory upregulation/activation of RhoA proteins in limk1 Ϫ/Ϫ mice, by evaluating the total and GTP-bound amounts of RhoA, Rac1 and Cdc42 in the lungs in the basal and LPSstimulated conditions. No differences were observed between limk1 ϩ/ϩ and limk1 Ϫ/Ϫ genotypes in either condition (supplemental Figure I) .
Importantly, although LPS still induced activation of RhoA in the lungs of limk1 Ϫ/Ϫ mice, the disruption of endothelial barrier function was significantly decreased in this genotype, therefore placing LIMK1 as a crucial regulator of endothelial permeability downstream of RhoA.
The mechanism of how LPS induces activation of RhoA is not understood and probably includes autocrine signaling from several receptors. For that reason, as a model to study the mechanism of LIMK1-mediated attenuation of RhoA-dependent disruption of endothelial barrier function in mouse lungs, we used a PAR-1 peptide, which has been shown to disrupt the endothelial barrier function both in vivo and in vitro 18 almost exclusively through activation of RhoA signaling cascade. 19 Although PAR-1 peptide induced the increase in Kfc in either genotype, in PAR-1challenged limk1 Ϫ/Ϫ mice, Kfc was significantly smaller and comparable to the Kfc of limk1 ϩ/ϩ mice in the basal conditions ( Figure 2A ).
To rule out other possible compensatory effects that might be associated with gene deletion in mice, we addressed the question of whether downregulation of LIMK1 would decrease permeability in cultured endothelial cells. Endogenous LIMK1 was downregulated in human umbilical vein endothelial cells (HUVECs) using siRNA ( Figure 2B ). Endothelial barrier function was evaluated using electric cell-substrate impedance sensor (ECIS). 20 Downregulation of LIMK1 in HUVECs resulted in the enhancement of endothelial barrier function ( Figure 2C ).
We previously showed that overexpression of wild type LIMK1 in HUVECs that possesses kinase activity resulted in the production of actin stress fibers and therefore in increased contractility of endothelial cells. 10 To determine if kinase activity of LIMK1 plays role in the disruption endothelial barrier, we overexpressed the wild type (wt) or kinase-dead (kd) 10 mutants of LIMK1 in HUVECs. kdLIMK1 had no effect, whereas overexpression of wtLIMK1 significantly decreased endothelial permeability ( Figure 2D ). The known target of LIMK1 is cofilin, an actin-depolymerizing factor. 21 To elucidate the mechanism of how LIMK1 regulates endothelial barrier disruption, we coexpressed nonphosphorylatable mutant of cofilin S3A-cofilin 21 with wtLIMK1. Importantly, coexpression of S3A-cofilin resulted in the complete recovery of phenotype induced by wtLIMK1 ( Figure 2E ), suggesting that LIMK1 exerts its effect on endothelial barrier disruption through phosphorylation of cofilin. 
LIMK1 Destabilizes Interendothelial Junctions
Barrier breakdown that is observed during inflammation, is regulated, in part, by the integrity of intercellular junctions. 5 To analyze ultrastructural changes of the endothelial barrier in limk1 Ϫ/Ϫ mice, we used quantitative transmission electron microscopy. Tight junctions, formed between adjacent endothelial cells in the capillary segment of the lungs, were detected as characteristic central dark element (fused outer layers) separated symmetrically by two light zones (central, lipid layers of unit) from two dark lines which are the cytoplasmic layers of unit membrane of each endothelial cell. 22 We did not observe differences in the structure of endothelium in the lungs of nonstimulated wild-type and limk1 Ϫ/Ϫ mice ( Figure 3A and 3B ). PAR1 peptide induced opening of interendothelial junctions in both genotypes, however quantitative morphometric analysis of the interendothelial junctions revealed that the number of open junctions was significantly smaller in limk1 Ϫ/Ϫ mice ( Figure 3C) .
To address the question about the role of LIMK1 kinase activity in morphology of endothelial junctions, we overexpressed kdLIMK1 or wtLIMK1 in HUVECs. Continuous junctional immunostaining was displayed by staining with anti-VE-cadherin antibody in HUVECs transfected with the kdLIMK1 (Figure 3D ). On the contrary, overexpression of wtLIMK1 resulted in appearance of intercellular gaps ( Figure  3D ). Importantly, destabilization of endothelial junctions, induced by wtLIMK1, was eliminated by coexpression of S3A-cofilin together with wtLIMK1 ( Figure 3D ). Similar results were obtained by staining with anti-Zonula Occludence-1 (ZO-1) antibody (data not shown).
To summarize, these data indicated that downregulation of LIMK1 enhanced endothelial barrier function both in vivo and in cell culture models. Lesser number of the open interendothelial junctions, as observed after PAR1 stimulation, could be the underlying cause of enhanced endothelial barrier function in limk1 Ϫ/Ϫ mice. The decrease in vascular permeability, attributable to the improvement of endothelial barrier function, could have contributed to the attenuation of edema formation in limk1 Ϫ/Ϫ mice. Mechanistically, LIMK1 exerted its effect on the disruption of endothelial barrier through phosphorylation of actin-depolymerizing factor, cofilin.
Reduced Diapedesis of limk1 ؊/؊ PMN in the Lungs During ALI
It is well established that infiltration of neutrophils in lungs, followed by tissue damage and lung edema, 3,4 plays a crucial role in the pathogenesis of ALI. [23] [24] [25] [26] Increased production of reactive oxygen species and proteolytic enzymes by neutrophils are known mechanisms underlying the development of tissue damage in ALI. 3 We tested whether production of reactive oxygen species or degranulation were decreased in limk1 Ϫ/Ϫ mice. Data showed that fMLP-or phorbol myristate acetate-induced O 2 Ϫ production in neutrophils as well as the total amount of superoxide produced did not differ between limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice (supplemental Figure IIA) . Neutrophil degranulation, a measure of proteolytic enzymes release, induced by fMLP or C5a (an anaphylatoxin, which is produced upon compliment activation in sepsis, 27 was similar in limk1 ϩ/ϩ and limk1 Ϫ/Ϫ PMN (supplemental Figure IIB) .
Next, we evaluated the extent of PMN extravasation into the lung tissues using hemotaxilin/eosin and leukocytespecific Leder staining. In both limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice, lung sections showed infiltration of neutrophils at 6 hours after LPS challenge. Notably, the number of neutrophils in the lungs of limk1 Ϫ/Ϫ mice was significantly smaller ( Figure  4A through 4C) .
Decreased number of neutrophils in lungs of limk1 Ϫ/Ϫ mice was not attributable to a decrease of the total amount of circulating neutrophils, because hemograms obtained before and after LPS injection showed no difference between limk1 ϩ/ϩ and limk1 Ϫ/Ϫ genotypes (supplemental Table I) .
ALI causes increased secretion of cytokines that promote neutrophil infiltration in the lungs. 3 We determined whether decreased cytokine production accounted for decreased neutrophil infiltration in limk1 Ϫ/Ϫ mice. Data showed that IL-6, MIP-1␣, TNF␣, and RANTES production in response to LPS did not differ between limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice (supplemental Figure III) .
Next, we investigated whether altered chemotactic activity in response to C5a and IL-8 (a chemokine that mediates the influx of neutrophils in the lungs during ALI 28, 29 ) contributed to decreased neutrophil infiltration in the lungs of limk1 Ϫ/Ϫ mice. Interestingly, directed chemotaxis of limk1 Ϫ/Ϫ PMNs was decreased by Ϸ20% in response to C5a ( Figure 4D) ; and by Ϸ40% in response to IL-8 ( Figure 4E ). That led us to conclusion that reduced number of infiltrated PMN in the lungs of limk1 Ϫ/Ϫ mice could be attributed to defects in limk1 Ϫ/Ϫ PMN chemotaxis.
Polymerization of actin is one of the early events during neutrophils activation and is required for the efficient che-motaxis. 30, 31 Considering a significant role of LIMK1 in actin polymerization, we analyzed C5a-induced changes in F-actin content in neutrophils from limk1 ϩ/ϩ and limk1 Ϫ/Ϫ mice. C5a-induced actin polymerization in limk1 Ϫ/Ϫ PMNs was significantly decreased and less sustained than in limk1 ϩ/ϩ PMNs ( Figure 4F ), thus providing an explanation for the defects in limk1 Ϫ/Ϫ PMN chemotaxis.
To summarize, genetic deletion of LIMK1 reduced the severity of ALI as was indicated by increased survival rate, decreased lung edema formation, and decreased PMN infiltration in the lungs. We propose that enhancement of the endothelial barrier function in lungs of limk1 Ϫ/Ϫ mice, through attenuation of RhoA-dependent signaling, along with a decrease of limk1 Ϫ/Ϫ PMN chemotaxis, attributable to defects in actin polymerization, were the underlying mechanisms that reduced the severity of ALI.
Discussion
In this study we demonstrated that genetic deletion of LIMK1 resulted in increased survival rate and decreased lung edema formation during ALI. For the first time, we provided the evidence that LIMK1 mediated RhoA-dependent endothelial barrier disruption during inflammation, induced by LPS or PAR-1 peptide. We suggested that improvement of the endothelial barrier function through attenuation of LIMK1mediated contractility; and decrease in PMN chemotaxis attributable to defects in actin polymerization were the underlying mechanisms that led to the reduction of the inflammatory responses in limk1 Ϫ/Ϫ mice during ALI. Downregulation of LIMK1 in vivo and in cell culture models resulted in the improvement of endothelial barrier function. Mechanistically, LIMK1 mediated disruption of endothelial barrier through phosphorylation of actin-depolymerizing factor, cofilin.
The pathogenesis of ALI includes disruption of endothelial barrier that leads to protein-rich edema, 2 which ultimately contributes to significant mortality of the patients affected with ALI. 1, 32, 33 Two actin cytoskeleton-dependent events are linked in a positive feed-forward cycle and are primarily responsible for the development of inflammatory response and lung edema during ALI: impairment of the endothelial barrier function and neutrophil-dependent tissue damage. [23] [24] [25] [26] 
Endothelial Barrier Function: Actin Cytoskeleton and LIMK1
Endothelial barrier function is controlled by the actomyosin cytoskeleton via regulation of the stability of intercellular junctions and tensile force within the monolayer. 34 -36 Here, for the first time, we showed that downregulation of LIMK1 resulted in decreased microvascular permeability in mouse lungs and improved endothelial barrier function both in vivo and in cell culture models. The lower basal permeability induced by downregulation of LIMK1 could be explained by reduced homeostatic tensile force in endothelial cells attributable to reduced actin polymerization. Our current data also showed that LIMK1 regulated disruption of endothelial barrier function primarily through phosphorylation of actin depolymerizing factor, cofilin ( Figure 2E ).
RhoA-ROCK-LIMK1 Signaling Axis Regulates Endothelial Barrier Disruption During Inflammation
It has been speculated that RhoA-mediated increase in actomyosin contractility plays a significant role in the disruption of endothelial barrier during inflammation. 36 Our current data together with the previous data from our laboratory 7 and others 8 provided the evidence that RhoA, through RhoA-ROCK-LIMK1 pathway, induced disruption of endothelial barrier during inflammation in mouse lungs in vivo. We showed here that LPS induced activation of both RhoA and LIMK1 in mouse lungs ( Figure 1D and supplemental Figure  I) . Notably, genetic deletion of LIMK1 significantly decreased LPS-and PAR-1-induced RhoA-mediated effects on the disruption of endothelial barrier function, without affecting the activation cycle of small GTPases per se (supplemental Figure I) . The mechanism of LPS-induced RhoA activation in endothelial cells in vivo still remains to be determined. It may include autocrine signaling through G protein-coupled receptors facilitated by anaphylatoxins, which are products of complement activation, 37, 38 or by chemokines, because it has been shown that chemokines exert their effects through at least nineteen G protein-coupled receptors. 39, 40 The Role of Other Organs and Cell Types in the Pathogenesis of ALI in limk1 ؊/؊ Mice Endothelial cells and neutrophils are two cell types primarily involved in the development of inflammatory response in lungs during ALI, therefore it is plausible to conclude that decreased microvascular permeability and PMN infiltration in limk1 Ϫ/Ϫ mice played the major role in increased survival rate during ALI. However, there is still a possibility that defects in other cell types also contributed to the protection against mortality, because LIMK1 is ubiquitously expressed in all tissues. 13 On the other hand, although we observed that LPS-induced lung edema formation was significantly suppressed ( Figure 1G ), about half of limk1 Ϫ/Ϫ mice were mortal by LPS treatment. This phenomenon can be also explained by the fact that the development of LPS-induced sepsis is manifested by multiple organ failure that includes kidney, lung, liver, etc. 41 Therefore, defects in multiple organs contribute to overall mortality, and suppression of lung edema formation may not be enough to completely abolish LPSinduced mortality.
PMN Diapedesis During ALI
Neutrophil migration into the lung tissue plays a crucial role in the pathogenesis of ALI. [23] [24] [25] [26] Activation of PMN results in the responses such as migration, degranulation, and phagocytosis, which are mediated by actin cytoskeleton. 42 We studied the role of LIMK1 during LPS-induced acute lung injury in 2 classes of cellular responses of PMN: (1) migratory (chemotaxis and transmigration) and (2) secretory (generation of oxygen radicals and secretion of lysosomal enzymes).
The transendothelial migration (diapedesis) is governed by coordinated action of both endothelial cells and neutrophils. In endothelial cells Rho protein-dependent 43 remodeling of the F-actin cytoskeleton and actin-associated interendothelial adherens junctions has been observed as the leukocyte completes diapedesis step. 44, 45 In neutrophils sequential activation of RhoA family small GTPases by microenvironmental signals leads to the actin cytoskeleton, which results in cell orientation and extension of extrapolary filopodia in the gap between endothelial cells. 30 Here we show that genetic deletion of LIMK1 decreased PMN infiltration in mouse lungs in vivo and produced defects in PMN chemotaxis in vitro ( Figure 4A through 4E) . Observed reduction in limk1 Ϫ/Ϫ PMN chemotaxis can be explained by perturbances in the dynamics of actin polymerization ( Figure 4F ).
It is reasonable to attribute decreased limk1 Ϫ/Ϫ PMN infiltration in lungs to defects in PMN chemotaxis. However, it is also possible that impaired actin cytoskeleton dynamics in endothelial cells contributed to reduced diapedesis, because it was shown that disruption of actin cytoskeleton in endothelial cells resulted in reduced transendothelial migration of monocytes. 46 We suggest that impaired actin cytoskeleton dynamics, which resulted in the enhancement of endothelial barrier, together with decreased PMN chemotaxis contributed to the decreased PMN diapedesis. The relative degree to which improvement of the endothelial barrier or decreased PMN chemotaxis contributed to the reduced PMN infiltration and lung injury remains to be determined.
PMN Superoxide Production and Degranulation
PMN cytoskeletal dynamics plays a crucial role in superoxide production and degranulation. 30 It was shown that inhibition of actin polymerization in activated neutrophils resulted in augmentation of superoxide anion production and degranulation induced by different agents. [47] [48] [49] Interestingly, we found that stimulus-induced superoxide production and degranulation in limk1 Ϫ/Ϫ PMN did not differ from limk1 ϩ/ϩ cells, although actin polymerization was impaired. Possible explanation underlying this phenomenon might be in the difference of the extent to which actin cytoskeleton dynamics was perturbed, because there are multiple ways to regulate actin cytoskeleton dynamics and LIMK1 affects only one of those.
To summarize, we demonstrated that the severity of acute lung injury was decreased in limk1 Ϫ/Ϫ mice, as was observed by increased survival rate, decreased edema formation, and PMN infiltration in the lungs. Based on our findings, we propose that organ-specific downregulation or inhibition of LIMK1 activity could be a potential strategy to reduce vascular leakage during many life-threatening diseases including ALI.
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